Titan Pharmaceuticals
TTNP
#10414
Rank
ยฃ4.59 M
Marketcap
ยฃ3.46
Share price
-3.76%
Change (1 day)
18.28%
Change (1 year)

Titan Pharmaceuticals (TTNP) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : ยฃ0.19 Million

According to Titan Pharmaceuticals 's latest financial reports the company's total liabilities are ยฃ0.19 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Titan Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ0.38 M-66.04%
2023-12-31ยฃ1.13 M-49.12%
2022-12-31ยฃ2.22 M5.29%
2021-12-31ยฃ2.11 M-36.69%
2020-12-31ยฃ3.34 M-45.83%
2019-12-31ยฃ6.16 M7.8%
2018-12-31ยฃ5.72 M-3.9%
2017-12-31ยฃ5.95 M34.18%
2016-12-31ยฃ4.43 M4.44%
2015-12-31ยฃ4.24 M-45.95%
2014-12-31ยฃ7.86 M2.41%
2013-12-31ยฃ7.67 M-74.13%
2012-12-31ยฃ29.66 M52.22%
2011-12-31ยฃ19.49 M178.48%
2010-12-31ยฃ6.99 M187.98%
2009-12-31ยฃ2.43 M
2007-12-31ยฃ2.14 M23.64%
2006-12-31ยฃ1.73 M-4.72%
2005-12-31ยฃ1.81 M-4.92%
2004-12-31ยฃ1.91 M2.41%
2003-12-31ยฃ1.86 M-24.09%
2002-12-31ยฃ2.46 M-38.11%
2001-12-31ยฃ3.97 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Vanda Pharmaceuticals
VNDA
ยฃ0.10 B 51,284.41%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
ยฃ2.22 M 1,028.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
ยฃ37.56 M 18,940.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ85.16 B 43,170,622.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ46.90 B 23,778,227.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
ยฃ0.63 B 319,528.90%๐Ÿ‡บ๐Ÿ‡ธ USA